Stay updated on Belzutifan + Cabozantinib in ccRCC Clinical Trial
Sign up to get notified when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.

Latest updates to the Belzutifan + Cabozantinib in ccRCC Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAccess to the NCT03634540 study record is blocked by a 403 Forbidden error, replacing the expected study details with a generic error page.SummaryDifference19%

- Check51 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, representing a metadata maintenance update to the record rather than changes to study content or outcomes.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page gains sponsor information and IPD-related metadata, plus expanded MeSH terms and keywords to reflect the study context. A previously shown 500 error page and Home link were removed, indicating the page now loads with updated content.SummaryDifference60%

- Check73 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, indicating a small system update rather than a change to trial details.SummaryDifference0.0%

Stay in the know with updates to Belzutifan + Cabozantinib in ccRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.